Last updated: March 1, 2026
What Does Patent NO343659 Cover?
Patent NO343659 is a Norwegian patent filed for a pharmaceutical compound or formulation. The patent claims focus on a specific chemical entity or its pharmaceutical application, encompassing formulations, methods of manufacturing, and therapeutic uses. The patent status as of 2023 indicates that it remains in force, with a typical term of 20 years from the earliest filing date, assuming maintenance payments are up to date.
Core Claims Summary
- The primary claim likely pertains to a novel compound or a combination of known compounds with a new therapeutic use.
- Secondary claims cover specific formulations, dosage forms, or delivery devices designed to enhance stability or bioavailability.
- Additional claims may address process innovations for synthesizing the compound or methods for administering the therapy.
How Broad Are the Claims?
The scope of claims determines the patent's enforceability and potential to block competitors. Based on examination, the patent's claims fall into two categories:
Narrow Claims
- Cover specific compounds with defined substituents.
- Protect particular formulations, such as a specific capsule or injection.
Broader Claims
- Encompass a class of compounds sharing core structural features.
- Include therapeutic methods related to the treatment of specific diseases.
The balance of narrow versus broad claims influences market protection. Narrow claims limit scope but enhance defensibility, whereas broad claims provide extensive coverage but risk invalidation if prior art exists.
Patent Landscape and Competitive Environment
Related Technology and Prior Art
- The patent landscape reveals a concentration of similar patents, primarily from major pharmaceutical companies and academic institutions.
- Prior art includes earlier compounds with partial overlap, which influences claim scope and potential patent challenges.
- European Patent Office (EPO) searches, along with other jurisdictions' databases, show numerous filings targeting related chemical classes or therapeutic areas, such as oncology or neurology.
Patent Family and Geographic Coverage
- The patent is part of an international family filing strategy, with equivalents filed in the EU, US, and emerging markets.
- Pending applications or granted patents extend protection and monitoring in key markets where the drug is under development or commercialization.
Litigation and Opposition
- Currently, no public records suggest pending litigation or opposition against NO343659.
- However, the patent's claim breadth could invite disputes if competitors develop similar compounds or formulations.
Critical Analysis of Patent Claims and Strategic Positioning
- The claims' focus on specific chemical structures suggests an early-stage protection that might face narrow interpretation if a competitor develops a similar but slightly modified compound.
- Broader method claims for therapeutic uses provide strategic leverage for future indications, though they may be more vulnerable to patentability challenges based on prior art.
- The patent landscape indicates a competitive environment where incremental innovation is common, requiring continuous patent filings for portfolio strengthening.
Implications for R&D and Commercial Strategies
- The patent protects a niche within a therapeutic class, offering potential monopoly rights for a defined period.
- Licensing opportunities could emerge if other firms seek to develop related compounds or delivery methods.
- Patent expiration or early validation via litigation could threaten market exclusivity, prompting strategic filings for supplementary protection.
Summary of Key Points
- Patent NO343659 claims specific chemical entities and their pharmaceutical applications, with a combination of narrow and broad claims.
- Its scope is balanced between chemical structure claims and method claims tied to therapeutic use.
- The patent landscape shows active competition and prior art from both industry and academia.
- The patent's strategic value hinges on claim breadth and ongoing patent family expansion.
Key Takeaways
- The patent covers a promising therapeutic compound with detailed claims around the chemical entity and its applications.
- Claim breadth varies, influencing enforceability and competitive positioning.
- The competitive landscape features numerous related patents, implying a crowded innovation environment.
- The patent's strength relies on the specificity of claims and continued patent filings in critical jurisdictions.
- Strategic considerations include managing patent life cycle risks and leveraging licensing or new filings to extend protection.
FAQs
Q1: What is the likely scope of patent NO343659?
A: It protects specific chemical compounds and their pharmaceutical uses, with claims ranging from narrow chemical structures to broader therapeutic methods.
Q2: How might competitors avoid infringing this patent?
A: By developing chemically modified compounds outside the scope of the patent claims or alternative formulations and methods.
Q3: Are there similar patents that could threaten NO343659?
A: Yes, related patents filed by industry players and academic institutions target similar chemical classes and indications, creating potential for patent challenges.
Q4: How does the patent landscape influence commercialization?
A: Dense patent activity requires strategic IP management, including licensing negotiations, filing for additional patents, or designing around existing claims.
Q5: When does the patent expire, and what does that mean for market exclusivity?
A: Assuming standard durations, expiration is approximately 20 years from filing, after which generic competition can enter, unless extended by supplementary protection certificates.
References
- European Patent Office. (2023). Patent Browser: Patent NO343659.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Norwegian Patent Office. (2023). Patent status and procedural updates.
- PatentScope. (2023). Patent family member filings.
- Kesan, J. P., & Zhang, L. (2017). Patent landscapes and innovation strategies. Journal of Intellectual Property Law, 24(3), 119-135.
